" /> Mycobacterium tuberculosis complex resistance panel:-:Pt:Isolate/Specimen:-:Molgen - CISMeF





Preferred Label : Mycobacterium tuberculosis complex resistance panel:-:Pt:Isolate/Specimen:-:Molgen;

LOINC status : ACTIVE;

LOINC display name : Mycobacterium tuberculosis complex resistance panel Molgen (Islt/Spec);

LOINC long common name : Mycobacterium tuberculosis complex resistance panel by Molecular genetics method;

LOINC short name : MTB cmplx resist Pnl Islt/Spm;

LOINC description : This panel contains results for the detection of mutations in the various MTB complex genes that indicate resistance to first- and second-line anti-tuberculous medications, including isoniazid, rifampin, ethambutol, pyrazinamide, the fluoroquinolones (moxifloxacin and ofloxacin) and the aminoglycosides (streptomycin, kanamycin, and amikacin). The predicted susceptibility (resistant, susceptible) to various medications based on the variants identified may also be reported.;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.